USANA Health Earnings Estimate

USNA Stock  USD 28.91  0.23  0.79%   
The next projected EPS of USANA Health is estimated to be 0.735 with future projections ranging from a low of 0.71 to a high of 0.76. USANA Health's most recent 12-month trailing earnings per share (EPS TTM) is at 2.19. Please be aware that the consensus of earnings estimates for USANA Health Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
USANA Health is projected to generate 0.735 in earnings per share on the 31st of March 2025. USANA Health earnings estimates show analyst consensus about projected USANA Health Sciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on USANA Health's historical volatility. Many public companies, such as USANA Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

USANA Health Revenue Breakdown by Earning Segment

By analyzing USANA Health's earnings estimates, investors can diagnose different trends across USANA Health's analyst sentiment over time as well as compare current estimates against different timeframes. As of March 17, 2025, Gross Profit is expected to decline to about 485 M. In addition to that, Pretax Profit Margin is expected to decline to 0.10
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

USANA Health Earnings Estimation Breakdown

The calculation of USANA Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of USANA Health is estimated to be 0.735 with the future projection ranging from a low of 0.71 to a high of 0.76. Please be aware that this consensus of annual earnings estimates for USANA Health Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.64
0.71
Lowest
Expected EPS
0.735
0.76
Highest

USANA Health Earnings Projection Consensus

Suppose the current estimates of USANA Health's value are higher than the current market price of the USANA Health stock. In this case, investors may conclude that USANA Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and USANA Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
178.17%
0.64
0.735
2.19

USANA Health Earnings History

Earnings estimate consensus by USANA Health Sciences analysts from Wall Street is used by the market to judge USANA Health's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only USANA Health's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

USANA Health Quarterly Gross Profit

175.06 Million

At present, USANA Health's Retained Earnings are projected to increase significantly based on the last few years of reporting. The current year's Earnings Yield is expected to grow to 0.08, whereas Retained Earnings Total Equity is forecasted to decline to about 258.5 M. The current year's Common Stock Shares Outstanding is expected to grow to about 27 M, whereas Net Income Applicable To Common Shares is forecasted to decline to about 65.4 M.
Hype
Prediction
LowEstimatedHigh
25.9429.0432.14
Details
Intrinsic
Valuation
LowRealHigh
26.0235.0338.13
Details
Naive
Forecast
LowNextHigh
24.8627.9631.06
Details
1 Analysts
Consensus
LowTargetHigh
46.8751.5057.17
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of USANA assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards USANA Health. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving USANA Health's stock price in the short term.

USANA Health Earnings per Share Projection vs Actual

Actual Earning per Share of USANA Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering USANA Health Sciences predict the company's earnings will be in the future. The higher the earnings per share of USANA Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

USANA Health Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as USANA Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of USANA Health should always be considered in relation to other companies to make a more educated investment decision.

USANA Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact USANA Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-04
2024-12-310.490.640.1530 
2024-10-22
2024-09-300.490.560.0714 
2024-07-23
2024-06-300.650.54-0.1116 
2024-04-30
2024-03-310.690.860.1724 
2024-02-06
2023-12-310.520.870.3567 
2023-10-24
2023-09-300.640.59-0.05
2023-07-25
2023-06-300.70.890.1927 
2023-04-25
2023-03-310.770.950.1823 
2023-02-07
2022-12-310.350.660.3188 
2022-10-25
2022-09-300.890.78-0.1112 
2022-07-26
2022-06-301.141.0-0.1412 
2022-04-26
2022-03-311.141.150.01
2022-02-08
2021-12-311.281.03-0.2519 
2021-10-26
2021-09-301.31.360.06
2021-07-27
2021-06-301.721.870.15
2021-04-27
2021-03-311.491.45-0.04
2021-02-09
2020-12-311.431.870.4430 
2020-10-20
2020-09-301.261.440.1814 
2020-07-21
2020-06-301.081.320.2422 
2020-04-21
2020-03-310.841.230.3946 
2020-02-04
2019-12-310.991.410.4242 
2019-10-22
2019-09-300.861.090.2326 
2019-07-23
2019-06-300.930.91-0.02
2019-04-30
2019-03-310.991.010.02
2019-02-05
2018-12-311.331.32-0.01
2018-10-23
2018-09-301.121.240.1210 
2018-07-24
2018-06-301.111.360.2522 
2018-04-24
2018-03-311.061.190.1312 
2018-02-06
2017-12-3111.110.1111 
2017-10-24
2017-09-300.911.020.1112 
2017-07-25
2017-06-301.150.98-0.1714 
2017-05-02
2017-03-310.920.91-0.01
2017-02-07
2016-12-310.940.87-0.07
2016-10-25
2016-09-301.071.20.1312 
2016-07-26
2016-06-301.021.030.01
2016-05-03
2016-03-310.910.89-0.02
2016-02-09
2015-12-3110.92-0.08
2015-11-03
2015-09-300.880.960.08
2015-08-04
2015-06-300.80.960.1620 
2015-05-05
2015-03-310.650.750.115 
2015-02-10
2014-12-310.960.83-0.1313 
2014-10-28
2014-09-300.680.680.0
2014-07-29
2014-06-300.750.68-0.07
2014-04-29
2014-03-310.650.57-0.0812 
2014-02-04
2013-12-310.610.710.116 
2013-10-22
2013-09-300.570.580.01
2013-07-23
2013-06-300.660.860.230 
2013-04-23
2013-03-310.580.640.0610 
2013-02-05
2012-12-310.610.640.03
2012-10-23
2012-09-300.530.590.0611 
2012-07-24
2012-06-300.460.560.121 
2012-04-24
2012-03-310.350.450.128 
2012-02-07
2011-12-310.430.440.01
2011-10-25
2011-09-300.380.410.03
2011-07-26
2011-06-300.40.440.0410 
2011-04-26
2011-03-310.330.350.02
2011-02-08
2010-12-310.420.38-0.04
2010-10-26
2010-09-300.320.40.0825 
2010-07-27
2010-06-300.310.350.0412 
2010-04-27
2010-03-310.250.310.0624 
2010-02-09
2009-12-310.290.330.0413 
2009-10-27
2009-09-300.250.260.01
2009-07-28
2009-06-300.220.280.0627 
2009-04-28
2009-03-310.20.220.0210 
2009-02-23
2008-12-310.280.280.0
2008-10-14
2008-09-300.30.25-0.0516 
2008-07-22
2008-06-300.30.310.01
2008-04-21
2008-03-310.220.230.01
2008-02-05
2007-12-310.330.340.01
2007-10-16
2007-09-300.330.350.02
2007-07-16
2007-06-300.320.330.01
2007-04-17
2007-03-310.310.320.01
2007-02-06
2006-12-310.290.310.02
2006-10-17
2006-09-300.280.280.0
2006-07-18
2006-06-300.260.280.02
2006-04-18
2006-03-310.260.25-0.01
2006-02-07
2005-12-310.260.270.01
2005-10-18
2005-09-300.240.260.02
2005-07-19
2005-06-300.230.240.01
2005-04-19
2005-03-310.210.230.02
2005-02-08
2004-12-310.210.230.02
2004-10-19
2004-09-300.190.190.0
2004-07-20
2004-06-300.170.180.01
2004-04-20
2004-03-310.140.150.01
2004-02-03
2003-12-310.140.160.0214 
2003-10-14
2003-09-300.140.140.0
2001-07-24
2001-06-300.010.010.0
2001-04-24
2001-03-310.010.010.0
2001-02-01
2000-12-310.020.020.0
2000-10-26
2000-09-300.010.010.0
2000-07-20
2000-06-300.010.010.0
2000-04-20
2000-03-310.040.03-0.0125 
2000-01-27
1999-12-310.050.060.0120 
1999-10-21
1999-09-300.040.040.0
1999-07-20
1999-06-300.040.040.0
1999-04-21
1999-03-310.040.040.0
1999-02-01
1998-12-310.050.050.0
1998-10-14
1998-09-300.040.050.0125 
1998-07-14
1998-06-300.040.050.0125 
1998-04-30
1998-03-310.030.040.0133 
1998-01-29
1997-12-310.040.040.0

About USANA Health Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of USANA Health earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current USANA Health estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as USANA Health fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings478.9 M502.9 M
Retained Earnings Total Equity396.3 M258.5 M
Earnings Yield 0.07  0.08 
Price Earnings Ratio 14.77  12.98 
Price Earnings To Growth Ratio(0.39)(0.37)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.74)
Earnings Share
2.19
Revenue Per Share
44.731
Quarterly Revenue Growth
(0.03)
Return On Assets
0.06
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.